Northwest, Biotherapeutics

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Northwest Biotherapeutics Maryland

View original content:https://www.prnewswire.co.uk/news-releases/northwest-biotherapeutics-announces-exclusive-in-license-of-portfolio-of-dendritic-cell-technology-and-intellectual-property-302174246.html

en | boerse | 67931787 |